SNYNF:OTCMKTS
Sanofi
78,55 US$
arrow_upward
+0,49%(+0,38) 1 d
15 oct, 12:34:26 GMT-4 · USD
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de SNYNF...
Abrir
78,55 US$
Alto
78,55 US$
Bajo
78,55 US$
Cap. burs.
98,14 mil M
Vol. medio
5,47 mil
Volumen
482,00
Máximo en 52 sem.
106,34 US$
Mínimo en 52 sem.
76,76 US$
Beta
0,32
Acciones en circulación
1207,77 M
N.º de empleados
75 mil
Abrir
78,55 US$
Alto
78,55 US$
Bajo
78,55 US$
Cap. burs.
98,14 mil M
Vol. medio
5,47 mil
Volumen
482,00
Máximo en 52 sem.
106,34 US$
Mínimo en 52 sem.
76,76 US$
Beta
0,32
Acciones en circulación
1207,77 M
N.º de empleados
75 mil
Noticias
De fuentes web y partners de noticias
Yahoo Finance
·
hace 31 minutos
Recursion (RXRX) Enters New Growth Phase as Sanofi Kicks Off Drug Collab, Shares Soar
Stocktwits
·
hace 2 horas
RXRX Stock Heads For Its Best Day In Over A Year – What’s Driving The Rally Today?
Quiver Quantitative
·
hace 2 horas
Recursion Pharmaceuticals Jumps After Sanofi Milestone, Clinical Updates, and $200 Million Financing
Perfil
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
Acerca de Sanofi
CEOBelén Garijo | Paul Hudson
Empleados74,8 mil
Fundación1973
SedeParís, Isla de Francia, Francia
Sector-
Sitio websanofi.com